SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001140361-16-088794
Filing Date
2016-12-05
Accepted
2016-12-05 14:01:18
Documents
1
Effectiveness Date
2016-12-05
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9676
  Complete submission text file 0001140361-16-088794.txt   10855
Mailing Address 20 N. MERIDIAN STREET SUITE 801 INDIANAPOLIS IN 46204
Business Address 20 N. MERIDIAN STREET SUITE 801 INDIANAPOLIS IN 46204 317-684-9196
Apexian Pharmaceuticals, Inc. (Filer) CIK: 0001560913 (see all company filings)

IRS No.: 450594393 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-275633 | Film No.: 162033376